Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Frost

Showing results (561-570 of 857) with videos related to

Pageof 86
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2001
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine researchJ A Langermans, P Andersen, D van Soolingen, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2014
Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1Shuyuan Chen, Raul A Bastarrachea, Brad J Roberts, et al.
Molecular and Cellular Biology|November 22, 2017
Sphingomyelin Metabolism Is a Regulator of K-Ras FunctionDharini van der Hoeven, Kwang-Jin Cho, Yong Zhou, et al.
Age and Ageing|February 13, 2026
"It's part of getting old": ageing perceptions and cultural beliefs underpin hip recovery and refracture prevention experiences: a qualitative studyBernadette Brady, Sacha Bossina, Amal Maximous, et al.
Journal of Medical Primatology|July 1, 2015
Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) modelPatrice A Frost, Shuyuan Chen, Marguerite J Mezzles, et al.
International Wound Journal|October 1, 2024
A randomised controlled phase II trial to examine the feasibility of using hyper-oxygenated fatty acids (HOFA) to prevent facial pressure injuries from medical devices among adults admitted to intensive care-A research protocolLeanne Hunt, Jessica Ingleman, Kathleen Brennen, et al.
Health Technology Assessment (Winchester, England)|February 18, 2011
A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET)K S Thomas, K Koller, T Dean, et al.
The New England Journal of Medicine|May 22, 2023
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin AmyloidPablo Garcia-Pavia, Fabian Aus dem Siepen, Erwan Donal, et al.
European Journal of Medicinal Chemistry|March 23, 2021
Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitorsPingyuan Wang, Dharini van der Hoeven, Na Ye, et al.
British Journal of Clinical Pharmacology|January 19, 2018
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjectsVidya Perera, Joseph M Luettgen, Zhaoqing Wang, et al.
Pageof 86

Showing results (561-570 of 857) with videos related to

Sort By:
Pageof 86
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2001
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine researchJ A Langermans, P Andersen, D van Soolingen, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2014
Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1Shuyuan Chen, Raul A Bastarrachea, Brad J Roberts, et al.
Molecular and Cellular Biology|November 22, 2017
Sphingomyelin Metabolism Is a Regulator of K-Ras FunctionDharini van der Hoeven, Kwang-Jin Cho, Yong Zhou, et al.
Age and Ageing|February 13, 2026
"It's part of getting old": ageing perceptions and cultural beliefs underpin hip recovery and refracture prevention experiences: a qualitative studyBernadette Brady, Sacha Bossina, Amal Maximous, et al.
Journal of Medical Primatology|July 1, 2015
Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) modelPatrice A Frost, Shuyuan Chen, Marguerite J Mezzles, et al.
International Wound Journal|October 1, 2024
A randomised controlled phase II trial to examine the feasibility of using hyper-oxygenated fatty acids (HOFA) to prevent facial pressure injuries from medical devices among adults admitted to intensive care-A research protocolLeanne Hunt, Jessica Ingleman, Kathleen Brennen, et al.
Health Technology Assessment (Winchester, England)|February 18, 2011
A multicentre randomised controlled trial and economic evaluation of ion-exchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET)K S Thomas, K Koller, T Dean, et al.
The New England Journal of Medicine|May 22, 2023
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin AmyloidPablo Garcia-Pavia, Fabian Aus dem Siepen, Erwan Donal, et al.
European Journal of Medicinal Chemistry|March 23, 2021
Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitorsPingyuan Wang, Dharini van der Hoeven, Na Ye, et al.
British Journal of Clinical Pharmacology|January 19, 2018
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjectsVidya Perera, Joseph M Luettgen, Zhaoqing Wang, et al.
Pageof 86